EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments. Cancer’s complex nature requires integration of advanced research data across national boundaries to enable progress. The Horizon Europe mission board for cancer has identified access to data, knowledge, and digital services – accessible across the European Research Area through federated infrastructures – as a key enabling condition for success. The better we organise cancer data across Europe, the better and faster we can bring the fruits of new biological and technical innovations to the benefit of EU citizens/patients. EOSC4Cancer’s well curated data sets will be essential input for reproducible and robust analytics and computational methods – including machine learning and artificial intelligence. EOSC4Cancer’s five use cases will cover the patient journey from cancer prevention over diagnosis to treatment, laying the foundation of data trajectories and workflows for future European Cancer Mission projects. EOSC4Cancer brings together a consortium of 29 organisations from 13 countries, including cancer research centres, research infrastructures, leading research groups, hospitals, and supercomputing centres. To make the developments sustainable, EOSC4Cancer will leverage the partners’ research infrastructures partners and the EOSC ecosystem. It will also serve the European Cancer Mission, by engaging with large international coalitions (e.g., ICGC-Argo, GA4GH, 1+MG/B1MG, Cancer Core Europe, European Cancer Information System, European Network of Cancer Registries, Innovative Partnership for Action Against Cancer Joint Action) and patients/survivors associations.
Network detailsCatalogueBB-OPBG
Biobanca Di Ricerca OPBG
Description
OPBG Research Biobank stores biological samples and associated data of children’s patients, collected since 1985. It is regulated by specific criteria for the evaluation of the requests for conservation and use of biological material and related data, taking into consideration the quality of the research projects motivating the requests. These criteria do not exclude third parties, in the aim of promoting international collaborations with associations, networks, research organizations and private subjects involved in translational and personalized medicine activities. A Management Committee evaluates the requests, availing of the advisory opinion of the OPBG clinical experts and researchers, and OPBG Ethics Committee authorizes the biobank activities, to guarantee the protection of the rights of patients and researchers. In 2017, DNV-GL certified OPBG Research Biobank’s quality system compliant to the ISO 9001:2015.
General Design
- Type
- Biobank
- Start/End data collection
- not available
- PID
- 21.12110/1.3AFE-8DD9-33CF
- External identifiers
- bbmri-eric:ID:IT_1547222650173780
Population
- Countries
- Italy
Contributors
Subpopulations
List of subpopulations for this resource
| Name | Description | Number of participants | |
|---|---|---|---|
No results for current selection |
Networks
Part of networks